2011

Welcome to Volume 10, Issue #1 (JANUARY 12, 2011) of Pharma Marketing News.

Welcome to Volume 10, Issue #9 (18 MAY 2011) of Pharma Marketing News.

The fear is that if the first steps by pharma to engage in social media conversation are too harshly scrutinized and criticized, the drug industry will shy away from getting more involved in social media.

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

Should a PR firm or an interactive marketing agency be in charge of pharma social media campaigns?

Welcome to Volume 10, Issue #11 (21 JUNE 2011) of Pharma Marketing News.

Many critics of pharma-supported CME believe this support leads to bias. Between 9 May 2011 and 13 September 2011, readers of Pharma Marketing News were asked to answer a few short questions relating to potential bias in industry-supported CME programs and how to limit the need for industry funding of CME. The results are summarized in this article.

While primary care physicians in general are frequent users of the Internet, oncologists see online sources of information as more important than PCPs and therefore may need less personal contact to learn about products. That was just one of the results from the 2011 Digital Life survey of 1,454 physicians summarized is this article.

Welcome to Volume 10, Issue #5 (10 MARCH 2011) of Pharma Marketing News.

The long-awaited social media guidance from the FDA -- whenever it arrives -- may turn out to be nothing more than a stamp of approval on activities in which the industry is currently engaged. Practically every issue that FDA guidance is expected to address has already been handled independently by a few pioneering pharmaceutical companies. Rather than waiting for FDA's anti climatic guidelines, Pharmaguy decided to publish The Pharmaguy Social Media Timeline™ now, at a time when the industry already has set precedents in every social media application.